OQROGet OQRO Pro
Insider trade

Ultragenyx Pharmaceutical (RARE)Officer sold ~$541K

Karah Herdman Parschauer, Officer at Ultragenyx Pharmaceutical, sold ~$541K of Ultragenyx Pharmaceutical shares.

~$541K
Approx. value · 13K sh @ $42.10
75K
Holds after · shares reported
Traded
Mar 3, 2025
Filed
Mar 5, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 27, 2025Insider · 1 personInsiders: 2 sales (~$128K)
  2. Feb 28, 2025InsiderCEO sold ~$1.06M of RARE shares in the open market
  3. Mar 3, 2025 · this disclosureInsiderOfficer sold ~$541K of RARE shares in the open market

What came next

  1. Mar 3, 2025Insider · 6 peopleInsiders: 6 sales (~$5.0M)
  2. Mar 6, 2025InsiderCFO sold ~$72K of RARE shares in the open market
  3. Apr 21, 2025InsiderOfficer sold ~$8.5K of RARE shares in the open market
  4. May 5, 2025InsiderOfficer sold ~$20K of RARE shares in the open market
  5. Jun 20, 2025InsiderDirector sold ~$90K of RARE shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Ultragenyx Pharmaceutical

For Ultragenyx Pharmaceutical, OQRO holds 5 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RARE page.

Other recent filings by Karah Herdman Parschauer, EVP and Chief Legal Officer

The full history of Karah Herdman Parschauer, EVP and Chief Legal Officer is on the profile page.

How this filing works

Other disclosures at Ultragenyx Pharmaceutical

Everything OQRO holds on this company is on its RARE page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data